Torpedo Therapeutics
Torpedo Therapeutics is dedicated to advancing the field of neurological disorder treatment through high-precision, closed-loop deep brain stimulation (DBS) therapy. Their mission is to enhance the efficacy and safety of DBS by innovating electrode technologies and developing automated data analysis platforms. This approach aims to minimize side effects and improve long-term outcomes for patients with conditions such as Parkinson’s disease, Essential Tremor, Dystonia, and drug-resistant Epilepsy.
Industries
Nr. of Employees
small (1-50)
Products
High-density microelectrode lead
Implantable lead composed of many micro-scale electrodes for high spatial resolution sensing and stimulation in deep brain regions.
On-lead readout and stimulation electronics
Miniaturized implantable electronic chip for signal readout and stimulation control intended to be integrated with electrode leads.
Machine learning-based neural data analysis and control platform
Software platform that analyzes recorded neural signals with machine learning to make predictive assessments and drive automated stimulation adjustments.
High-density microelectrode lead
Implantable lead composed of many micro-scale electrodes for high spatial resolution sensing and stimulation in deep brain regions.
On-lead readout and stimulation electronics
Miniaturized implantable electronic chip for signal readout and stimulation control intended to be integrated with electrode leads.
Machine learning-based neural data analysis and control platform
Software platform that analyzes recorded neural signals with machine learning to make predictive assessments and drive automated stimulation adjustments.
Expertise Areas
- Closed-loop deep brain stimulation
- High-density neural interfaces
- Micro- and nano-fabrication for implantable devices
- Machine learning for neural signal analysis
Key Technologies
- Micro- and nano-fabrication
- High-density microelectrode arrays
- Closed-loop neural control systems
- Machine learning for neural data